| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.099 | 0.06 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.091 | 0.06 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.096 | 0.07 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.07 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.055 | 0.07 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.054 | 0.08 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.08 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |